Crossmark

Sequential quantification of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs) and overall survival after allogeneic HSCT

Crossref DOI link: https://doi.org/10.1038/s41409-025-02744-6

Published Online: 2025-11-29

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

de Miguel, Carlos

Briansó, Ferran

Alonso, Rosalía

Bautista, Guiomar

Espinosa, Luis

Manchado-Perdiguero, Carlos

Martínez-Muñoz, María E. https://orcid.org/0000-0002-6829-9710
Núñez, Lucía

Salcedo, Isabel https://orcid.org/0009-0007-1976-320X
Sánchez-Peral, Ali

Duarte, Rafael F. https://orcid.org/0000-0002-5240-9815
License Information

Text and Data Mining valid from 2025-11-29

Version of Record valid from 2025-11-29
More Information

Article History

Received: 17 October 2024

Revised: 15 September 2025

Accepted: 4 November 2025

First Online: 29 November 2025

Competing interests

: FB, CMP and ASP are employees of Roche Diagnostics (Barcelona, Spain), which LightCycler® 480/TREC-KREC-ACTB Platform was used for the measurement of TRECs/KRECs in this study. CdM work was partly funded by CDTI’s Project # IDI-20180259. No other authors have any relevant conflicts of interest to disclose for the work presented here.

Document is current

Any future updates will be listed below